Company recalls 80 lots of valsartan because of cancer fears.

12 days ago

Another company that recalls that the medicine for Valsartan blood pressure because of the possibility that the tablets contain small amounts of carcinogenic compounds.

Aurobindo Pharma USA, Inc. Voluntarily, 80 tablets of the faction that may contain N-nitrosodiethylamine (NDEA), classified as a possible carcinogen. This announcement, which took place on New Year's Eve, indicates that the company has not received any reports of drug-related adverse reactions yet.

Patients taking medication should call their pharmacist or doctor to find alternative medicine. They also should not stop using the tablets until they find the appropriate substitute, according to the notice of appeal.

Consumers can contact the company at 1-866-850-2876 or [email protected]

Teva Pharmaceuticals voluntarily reported two drugs in November on the same concerns. In August, the Food and Drug Administration (FDA) announced an increased withdrawal of faction, these products may contain impurities.